Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects

Anti-vascular endothelial growth factor (anti-VEGF) therapies have become the standard of care in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), resulting in a remarkable decrease in disease-related vision loss. However, the need for regular in...

Descripción completa

Detalles Bibliográficos
Autores principales: Garweg, Justus G., Blum, Claudine A., Copt, René-Pierre, Eandi, Chiara M., Hatz, Katja, Prünte, Christian F., Seelig, Eleonora, Somfai, Gábor M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011261/
https://www.ncbi.nlm.nih.gov/pubmed/36633780
http://dx.doi.org/10.1007/s40123-023-00647-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011261/
https://www.ncbi.nlm.nih.gov/pubmed/36633780
http://dx.doi.org/10.1007/s40123-023-00647-7

Ejemplares similares